Search results
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
The Topeka Capital-Journal via Yahoo News· 2 days ago"Texas' claims are made under their consumer protection act, so there are some differences. In...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 2 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
Barrons.com· 1 day agoPfizer currently dominates the market for pneumococcal vaccines, which protect against bacterial...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 1 day ago"MSD competes with Pfizer in pneumococcal vaccine market after FDA approval " was originally created...
Merck wins U.S. approval for pneumonia vaccine to rival Pfizer’s
Crain's New York Business· 2 days agoCapvaxive has the potential to become the preferred vaccine given studies have shown it protects...
New Pneumococcal Vaccine Approved
Medscape· 2 days agoThe new vaccine covers eight serotypes not protected by other vaccines already on the market.
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 4 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 5 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 6 days agoAs such, people who contract KP...and are likely declining in one—Oklahoma. Do Vaccines Protect...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation...
NewMediaWire via Yahoo Finance· 2 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...